Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganfort in Glaucoma or Ocular Hypertension
NCT00332072Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2001
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bimatoprost + timolol in Glaucoma, ocular hypertension, sponsored by Allergan. Started Aug 2001; status: completed.
02
Drugs
bimatoprost + timolol
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00332072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332072.